JAMA Network
What The Study Did: This study evaluated the effectiveness of two doses of the Pfizer/BioNTech COVID-19 vaccine against SARS-CoV-2 infection among 542 adolescents ages 12 to 18.
Authors: Carlos R. Oliveira, M.D., Ph.D., of the Yale School of Medicine in New Haven, Connecticut, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2022.0935)
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
